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Résumé de l'article : 
L'hyperplasie intimale est un processus de remodelage vasculaire ubiquitaire après 
une lésion, pouvant menacer la perméabilité de tout type de reconstruction 
vasculaire. Les mécanismes physiopathologiques impliqués dans le développement 
de l'hyperplasie intimale ne sont que partiellement élucidés. Il est par conséquent 
nécessaire d'effectuer des recherches complémentaires afin d'en améliorer la 
compréhension et ainsi permettre l'élaboration de nouvelles stratégies 
thérapeutiques médicamenteuses. 
La culture de veines en milieu statique permet le développement de l'hyperplasie 
intimale. Ce modèle maintient la viabilité tissulaire, comme décrit précédemment 
dans d'autres études, mais empêche l'analyse des paramètres hémodynamiques. La 
mise au point d'un modèle de perfusion in vitro permettant la perfusion de 
segments vasculaires représente une approche expérimentale intégrant les 
différents facteurs hémodynamiques. 
Le système de perfusion (Ex Vivo Vein Support System) que nous avons élaboré 
conserve l'intégrité pariétale ainsi que les propriétés vasomotrices des veines pour 
une durée de 14 jours. Cette étude démontre que les deux modèles pennettent le 
développement de l'hyperplasie intimale. Toutefois, les propriétés vasomotrices 
ainsi que l'influence des paramètres hémodynamiques ne peuvent être analysées 
que par l'utilisation du système de perfusion. Ce dernier a permis de perfuser des 
vaisseaux humains sans contamination bactérienne tout en maintenant l'intégrité 
cellulaire. Ce modèle de perfusion se rapproche plus des conditions 
hémodynamiques rencontrées in vivo que le modèle statique. 
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Background. Intimai hyperplasia (IH) is a vascular 
remodeling process which often leads to failure of ar-
terial bypass or hemodialysis access. Experimental 
and clinical work have provided insight in IH devel-
opment; however, further studies under precise con-
trolled conditions are required to improve therapeutic 
strategies to inhibit IH development. Ex vivo perfusion 
of human vessel segments under standardized hemo-
dynamic conditions may provide an adequate experi-
mental approach for this purpose. Therefore, chroni-
cally perfused venous segments were studied and 
compared to traditional static culture procedures 
with regard to functional and histomorphologic char-
acteristics as well as gene expression. 
Materials and methods. Static vein culture allowing 
high tissue viability was performed as previously de-
scribed. Ex vivo vein support system (EVVSS) was per-
formed using a vein support system consisting of an 
incubator with a perfusion chamber and a pump. 
EVVSS allows vessel perfusion under continuons flow 
while maintaining controlled hemodynamic condi-
tions. Each human saphenous vein was divided in two 
parts, one cultured in a Pyrex dish and the other part 
perfused in EVVSS for 14 days. Testing of vasomotion, 
histomorphometry, expression of CD 31, Factor VIII, 
MIB 1, a-actin, and PAI-1 were determined before and 
after 14 days of either experimental conditions. 
Results. Human venous segments cultured under 
traditional or perfused conditions exhibited similar 
IH after 14 days as shown by histomorphometry. 
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Smooth-muscle cell (SMC) was preserved after chronic 
perfusion. Although integrity of both endothelial and 
smooth-muscle cells appears to be maintained in both 
culture conditions as confirmed by CD31, factor VIII, 
and a-actin expression, a few smooth-muscle cells in 
the media stained positive for factor VIII. Cell-
proliferation marker MIB-1 was also detected in the 
two settings and PAI-1 mRNA expression and activity 
increased significantly after 14 days of culture and 
perfusion. 
Conclusion. This study demonstrates the feasibility 
to chronically perfuse human vessels under sterile 
conditions with preservation of cellular integrity and 
vascular contractility. To gain insights into the mech-
anisms leading to IH, it will now be possible to study 
vascular remodeling not only under static conditions 
but also in hemodynamic environment mimicking as 
closely as possible the flow conditions encountered in 
reconstructi ve vascular surgery, © 2004 Elsevier Inc. Ail rights 
reserved. 
Key Words: ex vivo perfusion; vein culture; saphe-
nous vein; intimai hyperplasia; histomorphometry; im-
munohistochemistry; fibrinolytic factor; PAI-1; flow. 
INTRODUCTION 
Intimal hyperplasia (IH) development is one of the 
leading causes of failure after vascular interventions, 
irrespective of the procedure performed (bypass sur-
gery, percutaneous dilation, stent deployment) [1-5]. 
IH is characterized by proliferation of smooth-muscle 
cells (SMC) and their migration through the internal 
elastic lamina into the sub-intimal layer with produc-
tion of extra-cellular matrix (ECM) proteins. IH typi-
cally occurs between 1 and 12 months after interven-
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tion. The pathogenesis of IH is not fully understood. 
Severa! authors have suggested that a combination of 
physical, hemodynamic, cellular, and humoral factors 
may contribute to IH development [6-9]. Animal mod-
13ls have markedly contributed to the understanding of 
these mechanisms, although it was demonstrated that 
IH in humans was different [10, 11]. A number of 
investigators have studied IH development in organ 
culture of human saphenous veins [8]. In this mode! 
integrity of vessel wall is maintained up to 14 days and 
allows us to study the interactions between endothe-
lium and SMC. However, a major limitation of this 
experimental mode! is the absence of flow through the 
vesse! segment. IH development has been associated 
with the presence of peculiar local hemodynamic con-
ditions such as turbulent flow, low shear stress, flow 
separations [12, 13]. Indeed, Do brin et al. described in 
an animal mode! a correlation between the blood flow 
through a vesse! or a graft and the IH development 
with low shear stress being associated with increased 
IH in their mode! [14]. The endothelium plays a key 
role in the detection of shear stress and its translation 
to the vascular wall [15, 16]. 
The Ex Vivo Vein Support System (EVVSS) allows us 
to assess the biological response of the low-flow per-
fused segments under standardized and reproducible 
conditions. Low shear stress conditions were applied to 
the veins to produce maximal intima! proliferation 
[14]. Previous studies have shown that non-perfused 
human saphenous vein cultures allow us to study the 
development ofIH up to 14 days. We hypothesized that 
the same observation could be demonstrated in our ex 
vivo perfusion system. In the present study we inves-
tigated the impact of low shear stress perfusion on the 
biological response of human venous segments (endo-
thelial and muscular layers) and compared it to non-
perfused organ culture of the same veins. 
MATERIALS AND METHODS 
Harvesting of human saphenous vein. All procedures were ap-
proved by the Ethical Committee of the University of Lausanne. 
Surplus segments of non-varicose human saphenous vein were ob-
tained from nine patients (mean age, 56.5 ± 0.5; three females, six 
males) undergoing lower limb bypass surgery. The greater saphe-
nous vein was harvested and immediately stored at 4 °C in a calciU:m-
free Krebs solution (in mmol/L: NaCI 118; KCI 4.7; MgS04 1.2; 
KHP04 1.2; NaHC0 3 25; EDTA sodium 0.026; glucose 11.1). Vein 
segments were rapidly divided into three portions. One portion was 
used for the static culture; the second portion was used for the 
perfusion experiments and the third portion was snap-frozen in 
liquid nitrogen. 
Static vein culture. A 2-cm-long segment of the harvested vein was 
opened longitudinally with luminal surface uppermost. The verrous 
segment was pinned onto a Mersilene mesh (60 X 20 mm; Ethicon®, 
USA) in a Petri dish containing a layer of Sylgard 184 resin (Dow 
Corning, Seneffe, Belgium). The vein was then èovered with 5 ml of the 
culture medium (M 199, 10% newborn calf serum, 1 % antibiotic-
antimycotic solution: penicillin G, 10,000 U/ml; streptomycin sulfate, 
10,000 µg/ml; amphotericin B, 25 µg/ml; gentamicin, 5 µg/ml; Life 
FIG. 1. Picture of flow model. (1) Perfusion lamp; (2) pressure 
control; (3) fluid reservoir; (4) perfusion chamber; (5) vein segment; 
(6) ultrasound flow meter; (7) silicone peroxide treated tubing. (Color 
version of figure is available online.) 
Technologies, Inc., Invitrogen Corp., USA). Medium was changed every 
2 days until the end of the experiments [17, 18]. 
Ex vivo vein pe1fusion. Harvested verrous segments of 3 cm 
(mean interna! diameter: 3.03 ± 0.5 mm) were perfused in the 
EVVSS as previously described [19-23]. Briefly, vein segments were 
connected to a perfusion pump (LIS, Masterflex, Cole-Parmer Instru-
ment Co., USA) by silicone peroxide treated tubing (interna! diam-
eter, 3.2 mm) (Ismatec, Switzerland) and stored at 37°C (±0.l °C) 
inside a perfusion chamber placed in a cell culture incubator (Model 
· 310, Forma Scientific Inc., Marietta, OH, USA) (Fig. 1). The culture 
medium was used as perfusion solution. Because of the limited 
amount of human vein, we were constrained to use only one flow 
condition. The pH was kept constant at 7.4 (±0.01) using a COipH 
algorithm based on the Henderson-Hasselbach equation [20]. Vein 
segments were perfused for 14 days and the culture media were 
changed every 2 days. 
Vasomotion assessment. Vasomotion of saphenous vein wall 
(intima-media) was performed according to Radnoti® for each vessel 
segment before and after perfusion. Changes in isometric tension, 
induced by exposure of the vein to increasing concentrations of 
Noradrenaline and sodium nitroprussiate (SNP), were measured. 
Briefly, a 3-mm-long ring was eut from the harvested verrous seg-
ment and suspended between two stainless hooks in 20 ml Krebs 
solution at 37.0°C and gassed with 95% 0 2 and 5% C02 • One hook 
was fixed to a force transducer (Statham Universal, USA) recording 
changes in isometric tension. The segment was kept for 1 h with a 
fixed pretension of 1.6 g defined as the precontracted state [24]. As 
the vein segments were longitudinally opened for organ culture, no 
vasomotion testing could be assessed after a 14-day culture. We 
measured contractions to cumulative doses (lo-s to 10-' M) of NA. 
After submaximal precontracted (with 10-6 M NA), relaxations were 
serially determined to an endothelial-dependent agonist acetylcho-
line (Ach) and to an endothelial-independent agonist SNP. 
Histological, histomorphometrical, and immunohistochemical 
analysis. For each vein, a 5-mm-thick ring was harvested before 
and after perfusion. After fixation in 4% formalin, vein segments 
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FIG. 2. (A) Dose-dependent vasoconstriction of vein segments after administration of NA. (B) Dose-dependent relaxation of vein 
segments after administration of SNP. (C) Dose-dependent relaxation of vein segments after administration of Ach. 
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FIG. 3. Verrous wall before (A) and after (B) a 14-day perfusion 
showing IH development. (Color version of figure is available online.) 
were paraffin embedded and 5-µ,m-thick sections were analyzed. 
Hematoxylin-eosin staining was used for histological analysis and 
Miller staining was used for histomorphometric assessment. For 
histomorphometry, digital pictures were taken and histomorphomet-
ric measurements performed with a specially designed software (KS 
400, Zeiss®, Germany) using a standardized protocol. Twenty-four 
measurements of the intima and media were processed for each 
sample at magnifications of X20 and Xl.25, respectively. Immuno-
histochemistry was performed with the following five antibodies: 
monoclonal antibody CD31 (1:40; Dako, Denmark), monoclonal an-
tibody CD34 (1:800; Immunotech, France), and polyclonal or mono-
clonal anti-human Von Willebrand factor (1:1000; Dako), monoclonal 
anti-smooth muscle actin (1:10,000; Sigma, USA), and monoclonal 
anti-human Ki 67 antigen (MIB-1, 1:50; Dako). Antibody binding 
was revealed using the avidin-biotin peroxidase technique. Prolif-
eration cell-marker Ki 67 was quantified by cell-counting technique 
in a calibrated micrometer grid at a magnification of X40. In each 
field, all cells were counted, and the number of positively stained 
cells was expressed as a percentage of total cells, to obtain the MIB-1 
index. A minimum of seven fields was quantified per section. 
Analysis of PAI-1 gene expression. This analysis was performed 
by N orthern blot. A ring of 10 mm was eut of the harvested vein 
segment, before and after perfusion, snap frozen in liquid nitrogen, 
and stored at -70°C. Total RNA was prepared as follows: frozen 
segments were homogenized using a Polytron (K:inematica, USA) 
and total RNA was extracted using the RNeasy kit (Qiagen, USA). 
Five micrograms of total RNA was then separated on a 1.2% 
agarose-formaldehyde gel in morpholine propanesulfonic acid run-
ning buffer, transferred on Biodyne A m'embrane (Pall, USA), UV 
crosslinked (Stratagene, USA), and prehybridized at 65°C in a solu-
tion containing 1.5X SSPE, 7% SDS, 10% polyethylene glycol 8000, 
50 mg/ml heparin, and 0.1 mg/ml denatured salmon sperm DNA. 
Hybridization was carried out at 65°C in the same solution in the 
presence ofrandomly radiolabeled human PAI-1 cDNA probes. The 
blots were subsequently stripped and reprobed for human GAPDH. 
Signals were then quantified using an Instant Imager apparatus 
(Packard, USA) and signal intensities were normalized for the 
GAPDH signals. Normalized results were expressed as folds increase 
compared to results obtained from the same vein prior to perfusion to 
which an arbitrary value of 1 was given. Experiments were run in 
triplicate. 
Statistical analysis. The Student's t test for unrelated samples 
was used where appropriate. The Wilcoxon signed rank test was 
used for statistical analysis ofhistomorphometrical measurements of 
media and intima alterations. A two-tailed hypothesis was used and 
significance was accepted at P < 0.05. 
RESULTS 
Vasomotion testing showed a dose-dependent con-
traction to NA and a relaxation to SNP before and after 
experimental exposure in each segment (Fig. 2A, B). 
There was no significant difference regarding the con-
traction and relaxation response between the control 
and the perfused veins after 14 days. These results 
confirmed the preserved contractility of SMC after the 
14-day perfusion period. No venous segment before and 
after perfusion showed relaxation to Ach (Fig. 2C). 
Vessel wall integrity was determined by analysis of 
hematoxylin-eosin-stained vein sections (Fig. 3). No 
evidence of cellular degeneration was found in the con-
trol, the static vein segments, and the perfusion set-
ting. 
Histomorphometrical Analysis 
Measurement of intimal and sub-intimal layers, cor-
responding to IH, revealed a significant thickening of 
perfused vein segments as compared to baseline values 
observed prior to perfusion and culture (P < 0.05). 
However, there was no statistical difference in intimal 
thickening between culture and perfusion (P > 0.05) 
(Fig. 4). Significant thinning of the media was observed 
in the culture in comparison with the perfusion system. 
Immunohistochemical Assessment 
Expression of anti-CD31 revealed 19.7 and 8% of 
endothelial caver in the culture and the perfused set-
ting, respectively. This difference was not significant. 
No anti-CD34 positivity was observed in either control 
or treated vessels. However, anti-factor VIII staining 
demonstrated 94% of control endothelial caver, and 86 
and 83% in the culture and the perfused models, re-
spectively. Presence of SMC was confirmed by a-actin 
staining in all segments in the sub-intimal space and 
the media. The adjunction of Miller elastin stain with 
anti-a-actin allows us to localize SMC in the sub-
intimal layer and to differentiate these cells from mes-
enchymal cells. 
No MIB-1 antibody staining was found in the control 
veins, whereas 2.7 and 6.4% of the SMC stained posi-
tive for this proliferation marker in static culture and 
perfusion setting, respectively (Fig. 5). 
N orthem Blot Analysis 
A significant increase of PAI-1 mRNA expression 
was detected after vein static culture (P = 0.002) and 
perfusion (P = 0.002) as compared to baseline values. 
However, there was no significant difference of PAI-1 
mRNA expression between the two settings (Fig. 6). 
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DISCUSSION 
Several reports indicated that vein segments rem~in 
usually viable as assessed by histology and vasomot10n 
during a 14-day period of culture contrary to l?nger 
duration of culture [8]. Preservation of cellular mteg-
rity and vascular contractility.was also demonstrated 
in our previous study comparmg ~uma:r: venous seg-
ments after 7 and 14 days ofperfus10n. Histomor~h~m­
etry indicated that IH development reached stati~tical 
significance after 14 days. Howeve_r, long~r dm:at10n of 
perfusion led to vessel wall necrosis and mfect10n [24]. 
The present study demonstrates that vein exposure 
to EVVSS undergoes IH of the same magnitu~e as. d?es 
the vein culture with the advantage of mamtammg 
fiow conditions. Porter et al. described that mean arte-
rial shear stress (6-9 dyn/cm2) totally suppressed IH 
and that venous conditions (1-3 dyn/cm 2 ) only partly 
suppressed the response [7]. De~pite . o~r ü:iterest to 
compare various levels of perfusion, hmit~t10ns we~e 
due to the lack of human vascular matenal. Ii;- ~his 
preliminary and novel experiment, venous condit~ons 
were selected to obtain maximal IH development m a 
chronic fiow system and to compare ~t to the tra~iti?nal 
static culture model. A significant mcrease of mtimal 
and sub-intimal thickening was observed. as compare.cl 
to control vein segments after both perfus10n and static 
vein culture (P < 0.05). The degree of IH develop~ent 
was similar in both settings, although the mechamsms 
are different. Indeed, the longitudinal opening of the 
vessel in the culture is certainly the main trigger of the 
neointima formation [25]. The absence of fiow and 
shear stress in the culture may promote IH [24]. Shear 
stress appears to be one of the major stimuli in~uen.c­
ing the development of IH even if its exact role is still 
controversial [26-29]. In our perfusion system, the 
shear stress is in the low range (2-6 dyn/cm2~ an~ may 
not be sufficient for a proper endothelial activation to 
inhibit IH development. Indeed chronic reduction of 
blood flow has been shown to decrease r~ceptor­
mediated release of endothelium-derived relaxmg fac-
tors and to favor neointimal hyperplasia [14]. The ab-
sence ofpulsatile fiow and high stretch-inhibiting S11:C 
differentiation may also explain IH development m 
both settings. Even though the degree of IH was mo~e 
pronounced in the culture Petri dish, the changes did 
not reach statistical difference when comp~red to the 
perfusion conditions. The medial ~hi~nin~ m the cul-
ture may be explained by cell redrnt.nb"°;t10n an~ ph~­
notypic modifications of SMC resultmg ~n a rapid mi-
gration of the dedifferentiated SMC mto the sub-
intimal space. This is clearly demonstrat~d by the 
increase in the intima/media ratio observed. m the cul-
ture condition when compared to the perfus10n s:ystem. 
True viability of the venous segments may be d1fficult 
to assess. Potential methods might include vasomo-
tion, histology (nuclear density, relative amount of 
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FIG. 5. Perfusion index in each venous segment after culture (black columns) and perfusion (red columns) . 
acellular, apoptotic, or necrotic tissue), and metabo-
lism (LDH levels, ADP/ATP) assessment. We have re-
lied on cellular integrity (histology and preservation of 
contractility and relaxation) in this study, as a surro-
gate marker of vascular viability. 
EVVSS appears to be well-suited to conduct chronic 
perfusion study. Indeed, vein segments retained their 
reactivity to vasoactive drug infusion such as NA and 
SNP as demonstrated by preserved responses following 
chronic perfusion. In our hands, Ach did not induce any 
vasomotor response in any of the experimental condi-
tions. Histological and immunohistochemical analysis re-
vealed preservation of EC integrity in perfused and cul-
tured vein segments. We observed different expression 
patterns between the endothelial markers CD 31 and 
Factor VIII. These results suggest that EC maintain cel-
lular integrity. The positive staining of sub-intimal and 
medial spaces for Factor VIII suggest that EC may re-
lease Factor VIII in the ab-luminal space and diffuse into 
the vascular wall [30]. Culture media have been shown to 
be a major source of factor VIII; however, we did not find 
Factor VIII in our media. EC damaging/loss cannot be 
formally excluded as suggested by the absence of vaso-
motor responsiveness following Ach testing. Further-
more, the exposition of the sub-intimal layer after EC loss 
may partly be responsible for IH development in the 
perfusion setting. A great variability in proliferation in-
dex of the venous segments was observed based on MIB-1 
expression. Medial fibrosis and pre-existing IH in the 
vein at the time of harvesting may partly explain this 
variability [31]. 
The veins which were exposed to fiow show a greater 
proliferation index than those in static culture. Con-
sidering that no significant difference in IH was ob-
served between the two settings, one may conclude 
that different mechanisms are involved in the develop-
ment of IH. lt will be very interesting to submit these 
venous segments to pulsatile and different shear rates 
in future studies. 
The fibrinolytic system has recently been reported to 
play a major role in IH proliferation. Several authors 
demonstrated the involvement of plasminogen activa-
tor system in SMC migration [32]. The inactive pro-
enzyme plasminogen is activated to the proteolytic en-
zyme plasmin by two plasminogen activators, tissue 
plasminogen activator (tPA) and urokinase plasmino-
gen activator (uPA). The system is regulated by 
plasminogen-activator inhibitors (PAI), ofwhich PAI-1 
is thought to be the most important. PAI-1 has been 
shown to inhibit SMC in vitro and inactivation of the 
PAI-1 gene results in exaggerated neointimal thicken-
ing [33, 34]. Kahanen et al. described an up-regulation 
of PAI-1 mRNA expression in failing vein grafts after 
the development of IH in a clinical study [35]. Carme-
liet et al. suggested an inhibitory role of PAI-1 on 
cellular migration by observing an exaggerated intimal 
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FIG. 6. PAI-1 mRNA expression before, at 7 and 14 days ofvein 
culture and ex vivo vein perfusion, respectively. 
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proliferation secondary to injury in PAI-1-deficient 
mice [36]. Others demonstrated that PAI-1 inhibits 
SMC migration by limiting the binding ofvitronectin to 
its receptor [37]. Moreover, Arnman et al. observed an 
enhanced expression of PAI mRNA around the throm-
bus in occluded saphenous veins [38]. We focused on a 
single factor of the fibrinolytic system (PAI-1), due to 
the limited amount ofvein segments. Our results dem-
onstrated a significant increase of PAI-1 mRNA ex-
pression in veins exposed to continuous flow as well as 
in the static model. This confirms the observation by 
Redmond et al. demonstrating that PAI-1 released by 
flow-induced EC inhibits flow-induced SMC migration 
in vitro [39]. This suggests that despite a higher pro-
liferation index in continuous flow setting, the IH is of 
greater magnitude in culture because the migration of 
SMC is not inhibited in a the static condition by PAI-1 
and so the process of IH by ECM secretion by SMC is 
possible. 
In conclusion, we report the feasibility to chronically 
perfuse human venous segments, under sterile condi-
tions with preservation of cellular integrity and vascu-
lar contractility. The ex vivo perfusion system allows 
the development of IH under standardized conditions 
for up to 14 days. This model gives insights to study 
vascular wall remodeling and mechanisms leading to 
IH development not only under no-flow conditions but 
also in hemodynamic environment. 
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